These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1514034)

  • 1. Reduced natural killer cell activity in multi-drug resistant pulmonary tuberculosis.
    Ratcliffe LT; Mackenzie CR; Lukey PT; Ress SR
    Scand J Immunol Suppl; 1992; 11():167-70. PubMed ID: 1514034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced NK activity correlates with active disease in HIV- patients with multidrug-resistant pulmonary tuberculosis.
    Ratcliffe LT; Lukey PT; MacKenzie CR; Ress SR
    Clin Exp Immunol; 1994 Sep; 97(3):373-9. PubMed ID: 8082292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human natural killer T cells (NKT), NK and T cells in pulmonary tuberculosis: potential indicators for disease activity and prognosis.
    Zahran WA; Ghonaim MM; Koura BA; El-Banna H; Ali SM; El-Sheikh N
    Egypt J Immunol; 2006; 13(1):67-78. PubMed ID: 17974151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK cell activity in pulmonary tuberculosis.
    Yoneda T; Kasai M; Ishibashi J; Nishikawa K; Tokunaga T; Mikami R
    Br J Dis Chest; 1983 Apr; 77(2):185-8. PubMed ID: 6871086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell activity in patients with pulmonary tuberculosis and in healthy controls.
    Restrepo LM; Barrera LF; Garcia LF
    Tubercle; 1990 Jun; 71(2):95-102. PubMed ID: 2120829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The changes and the significance of cellular immune function in peripheral blood of patients with multidrug-resistant and extensively drug-resistant pulmonary tuberculosis].
    Yang Y; Tang SJ; Zhang Q; Sun H; Liu YD; Hao XH; Yao L; Gu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Feb; 34(2):109-13. PubMed ID: 21426728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell activity in tuberculosis.
    Onwubalili JK; Scott GM
    Br J Dis Chest; 1985 Jan; 79(1):67-76. PubMed ID: 2580544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell activity in multidrug-resistant pulmonary tuberculosis.
    Yildiz P; Kadakal F; Tütüncü Y; Deniz G; Gürel N; Adin S; Yilmaz V
    Respiration; 2001; 68(6):590-4. PubMed ID: 11786713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augumentation of natural killer activity with exogenous interleukins in patients with HIV and pulmonary tuberculosis coinfection.
    Ramana Rao PV; Rajasekaran S; Raja A
    AIDS Res Hum Retroviruses; 2008 Nov; 24(11):1435-43. PubMed ID: 19000024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced natural killer cell activity in patients with pulmonary tuberculosis.
    Morikawa F; Nakano A; Nakano H; Oseko F; Morikawa S
    Jpn J Med; 1989; 28(3):316-22. PubMed ID: 2739140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and immunological study on chronic intractable pulmonary tuberculosis--an immune spectrum in pulmonary tuberculosis].
    Yoneda T; Narita N; Mikami R; Shirai F
    Kekkaku; 1987 Oct; 62(10):489-95. PubMed ID: 3444192
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevated Natural Killer Cell-Mediated Cytotoxicity Is Associated with Cavity Formation in Pulmonary Tuberculosis Patients.
    Li S; Wang D; Wei P; Liu R; Guo J; Yang B; Zhang H; Lu J; Gao M; Pang Y
    J Immunol Res; 2021; 2021():7925903. PubMed ID: 34646890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence of CD5LOW+NK cells in normal controls and patients with pulmonary tuberculosis.
    Ishiyama T; Watanabe K; Fukuchi K; Yajima K; Koike M; Tomoyasu S; Tsuruoka N
    Immunol Lett; 1993 Aug; 37(2-3):139-44. PubMed ID: 7505001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis.
    Harker WG; Tom C; McGregor JR; Slade L; Samlowski WE
    Cancer Res; 1990 Sep; 50(18):5931-6. PubMed ID: 1975512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [THE USE OF "REAMBERIN" AS BIOLOGICAL RESPONSE MODIFIER TO INCREASE THE NATURAL KILLER CELLS' CYTOTOXICITY IN PATIENTS WITH LUNG TUBERCULOSIS].
    Kholamov AI; Mirzomogomedova VG; Chernoshey DA; Lizunov ES
    Eksp Klin Farmakol; 2015; 78(8):22-4. PubMed ID: 26591578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between multi-drug resistance and resistance to natural-killer-cell and lymphokine-activated killer-cell lysis in human leukemic cell lines.
    Treichel RS; Olken S
    Int J Cancer; 1992 Jan; 50(2):305-10. PubMed ID: 1370437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Natural killer cells in patients with pulmonary tuberculosis].
    Khomenko IS; Gergert VIa; Kolodiazhnaia NS
    Biull Eksp Biol Med; 1991 Jul; 112(7):76-8. PubMed ID: 1793866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis.
    Kumar NP; Sridhar R; Nair D; Banurekha VV; Nutman TB; Babu S
    Immunology; 2015 Apr; 144(4):677-86. PubMed ID: 25363329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Commemorative lecture of receiving Imamura Memorial Prize. NK cell in pulmonary tuberculosis from basic and clinical point of view].
    Yoneda T
    Kekkaku; 1996 Nov; 71(11):625-31. PubMed ID: 8958676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [NK cell activity and counts of T-lymphocyte subsets in pulmonary tuberculosis].
    Qin J
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Aug; 13(4):209-11, 254. PubMed ID: 2151030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.